Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Risperidone name brand?Pristiq cost without insurance?Keytruda primary u's patent expiration date?Cyclobenzaprine price?Lantus 100 units price?
See the DrugPatentWatch profile for trulicity
No. Trulicity is not a biologic. It is a small-molecule drug. Trulicity (dulaglutide) is a GLP-1 receptor agonist. Because dulaglutide is a drug product made with chemical synthesis rather than being produced as a biologic therapy (like many monoclonal antibodies), it is not classified as a biologic. [1]
Trulicity is a prescription medication used to treat type 2 diabetes. It works by mimicking GLP-1 activity, which helps increase insulin secretion in a glucose-dependent way and lowers blood sugar. [1]
Yes, because the regulatory pathways differ. If a product is a biologic, it can have biosimilars. If it’s not a biologic (as with Trulicity), the relevant equivalents are not biosimilars in the usual sense. (Search results and labeling will treat dulaglutide as a non-biologic small-molecule drug rather than a biologic candidate for biosimilar approval.) [1]
Other Questions About Trulicity :